Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cassava Sciences Inc SAVA

Healthcare
Cassava Sciences, Inc. is a biotechnology company focused on Alzheimer's disease. The Company's science is based on stabilizing, but not removing, a critical protein in the brain. The Company is focused on its product discovery and development efforts on disorders of the nervous system. Its lead therapeutic drug candidate, simufilam, is under clinical evaluation for the proposed treatment of... see more

Recent & Breaking News (NDAQ:SAVA)

CASSAVA SCIENCES DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Cassava Sciences and Encourages Investors to Contact the Firm

Business Wire October 25, 2021

SAVA FINAL DEADLINE TOMORROW: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Cassava Sciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 26 Deadline in Securities Class Action - SAVA

PR Newswire October 25, 2021

SAVA DEADLINE ALERT: Hagens Berman Announces that Cassava Sciences (SAVA) Investors with $250K+ Losses Have Opportunity to Lead Class Action Lawsuit, OCT. 26TH DEADLINE

Newsfile October 25, 2021

LAWSUITS FILED AGAINST KPLT, SAVA and ZEV - Jakubowitz Law Pursues Shareholders Claims

Accesswire October 25, 2021

Last Day to Actively Participate in Cassava Sciences, Inc. (SAVA) Class Action: Bronstein, Gewirtz & Grossman, LLC

Business Wire October 25, 2021

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Cassava Sciences, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 26, 2021 - SAVA

Newsfile October 25, 2021

DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Cassava Sciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile October 25, 2021

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of KPLT, SAVA and INNV

Accesswire October 25, 2021

Cassava Deadline Alert

Newsfile October 24, 2021

SAVA INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against Cassava Sciences, Inc.

Business Wire October 23, 2021

Cassava Update

Newsfile October 23, 2021

CASSAVA SCIENCES 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess Of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Cassava Sciences, Inc. - SAVA

Business Wire October 22, 2021

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SAVA, EAR and HYZN

Accesswire October 22, 2021

Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Class Action Lawsuit Against Cassava Sciences, Inc. (SAVA)

Business Wire October 22, 2021

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SAVA, EAR and ZEV

Accesswire October 22, 2021

DEADLINE TUESDAY NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Cassava Sciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile October 22, 2021

LAWSUITS FILED AGAINST SAVA, HYRE and SPPI - Jakubowitz Law Pursues Shareholders Claims

Accesswire October 22, 2021

SAVA Investors Have Opportunity to Lead Cassava Sciences, Inc. Securities Fraud Lawsuit

PR Newswire October 22, 2021

SAVA 4-DAY DEADLINE ALERT: Hagens Berman Alerts Cassava Sciences (SAVA) Investors to Lead Plaintiff Opportunity in Class Action, Encourages Investors with $250K+ Losses to Contact Firm's Attorneys Now

Newsfile October 22, 2021

INVESTOR ALERT: CASSAVA SCIENCES, INC. (SAVA) OCTOBER 26, 2021 CLASS ACTION LAWSUIT DEADLINE REMINDER: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Cassava Sciences, Inc.

Newsfile October 22, 2021